But where the business inducements enter unprecedented terrain is health and safety regulation. Próspera won’t impose rules so much as curate prix fixe and à la carte menus of rules.

Delgado has held talks with a controversial gene-therapy startup, Minicircle, to open a clinic in Próspera. It will be funded by a “network of crypto investors,” according to its CEO, Machiavelli Davis. Davis runs in biohacking circles, a set best known for self-administering untested gene therapies.